Advisory Committee on Immunization Practices; Cancellation of Meeting

---
identifier: "/us/fr/2022-26084"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Advisory Committee on Immunization Practices; Cancellation of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2022-26084"
section_name: "Advisory Committee on Immunization Practices; Cancellation of Meeting"
positive_law: false
currency: "2022-11-30"
last_updated: "2022-11-30"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2022-26084"
document_type: "notice"
publication_date: "2022-11-30"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "87 FR 73558"
fr_volume: 87
docket_ids:
  - "Docket No. CDC-2022-0136"
fr_action: "Notice."
---


#  Advisory Committee on Immunization Practices; Cancellation of Meeting

**AGENCY:**

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

**ACTION:**

Notice.

**SUPPLEMENTARY INFORMATION:**

Notice is hereby given of a change in the meeting of the Advisory Committee on Immunization Practices (ACIP); December 9, 2022, from 10 a.m. to 5 p.m., EST. The virtual meeting was published in the *Federal Register* on November 23, 2022, Volume 87, Number 225, pages 71641-71642. This meeting is being canceled in its entirety.

**FOR FURTHER INFORMATION CONTACT:**

Stephanie Thomas, ACIP Committee Management Specialist, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road NE, Mailstop H24-8, Atlanta, Georgia 30329-4027; Telephone: 404-639-8836; Email: *[email protected].*

The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and  Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,

Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.